Given that QFT-PLUS tests, which comprise four tubes to measure IFN-γ, measure helper and cytotoxic T cell responses separately and have a distinct standard to define indeterminate results compared to those QFT-GIT tests, it is possible that the diagnostic performance of the two assays could differ in patients with rheumatic diseases. Here, IFNG is linked to rheumatic disorder.